DOSAGE AND DURATION OF ETANERCEPT THERAPY FOR ANKYLOSING SPONDYLITIS: A META-ANALYSIS.

about

DOSAGE AND DURATION OF ETANERCEPT THERAPY FOR ANKYLOSING SPONDYLITIS: A META-ANALYSIS.

Item

http://www.wikidata.org/entity/Q48661188

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

DOSAGE AND DURATION OF ETANERCEPT THERAPY FOR ANKYLOSING SPONDYLITIS: A META-ANALYSIS.

@en

DOSAGE AND DURATION OF ETANERCEPT THERAPY FOR ANKYLOSING SPONDYLITIS: A META-ANALYSIS.

@nl

type

Item

label

DOSAGE AND DURATION OF ETANERCEPT THERAPY FOR ANKYLOSING SPONDYLITIS: A META-ANALYSIS.

@en

DOSAGE AND DURATION OF ETANERCEPT THERAPY FOR ANKYLOSING SPONDYLITIS: A META-ANALYSIS.

@nl

prefLabel

DOSAGE AND DURATION OF ETANERCEPT THERAPY FOR ANKYLOSING SPONDYLITIS: A META-ANALYSIS.

@en

DOSAGE AND DURATION OF ETANERCEPT THERAPY FOR ANKYLOSING SPONDYLITIS: A META-ANALYSIS.

@nl

P1476

DOSAGE AND DURATION OF ETANERCEPT THERAPY FOR ANKYLOSING SPONDYLITIS: A META-ANALYSIS.

@en

P2093

Heeyoung Lee

http://www.w3.org/2001/XMLSchema#string

Hyunjun Shim

http://www.w3.org/2001/XMLSchema#string

Jihyung Lee

http://www.w3.org/2001/XMLSchema#string

Seungyeon Song

http://www.w3.org/2001/XMLSchema#string

Wonku Kang

http://www.w3.org/2001/XMLSchema#string

Younjoo Jung

http://www.w3.org/2001/XMLSchema#string

P2860

Bias in meta-analysis detected by a simple, graphical test

Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis

Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis.

Treatment of ankylosing spondylitis with TNF blockers: a meta-analysis.

Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a randomised double-blind placebo-controlled study (SPINE).

Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis.

Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis.

Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis.

P304

69-75

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1017/S0266462317000150

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eunyoung Kim

P577

2017-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28434410

http://www.w3.org/2001/XMLSchema#string